masoprocol has been researched along with Leukemia, Promyelocytic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blomhoff, R; Drevon, CA; Farrants, AK; Finstad, HS; Holme, JA; Kolset, SO; Wiger, R | 1 |
| Ayyub Khan, M; Hoffbrand, AV; Tateson, JE; Wickremasinghe, RG | 1 |
2 other study(ies) available for masoprocol and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells.
Topics: Apoptosis; Arachidonic Acid; Cell Differentiation; Cell Division; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Unsaturated; Flow Cytometry; Gene Expression Regulation, Leukemic; Granulocytes; Humans; Indomethacin; Leukemia, Promyelocytic, Acute; Masoprocol; Monocytes; Necrosis; Neoplastic Stem Cells; Proteoglycans; Proto-Oncogene Proteins c-myc; Respiratory Burst; Tretinoin; Tumor Cells, Cultured; Vesicular Transport Proteins | 1994 |
Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Benzeneacetamides; Blast Crisis; Burkitt Lymphoma; Cell Division; Epoprostenol; Hematopoietic System; Humans; Hydroxamic Acids; Indoles; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Masoprocol; Tumor Cells, Cultured | 1993 |